Grown Rogue Archives - Green Market Report

Adam JacksonDecember 13, 2022


Grown Rogue International Inc. (CSE: GRIN) (OTC: GRUSF) posted temperate earnings results that show rising revenue and positive free cash flow. The craft cannabis company operating in Oregon and Michigan reported its unaudited results for the fourth quarter ending October 31.

Grown Rogue posted revenue of $5.07 million, a 35% rise versus $3.76 million in the fourth quarter last year. It also improved over the previous quarter’s revenue of $4.2 million. Net loss totaled $397,324 for the quarter, down from a $431,000 net income in the same time last year.

“I couldn’t be more thrilled about our record revenue and adjusted EBITDA, closing out a record year including achieving positive free cash flow for the year,” said CEO Obie Strickler. “It’s even more exciting to watch our team continue to increase market share in Oregon and Michigan by staying true to our focus towards ensuring customers experience leading craft quality and genetics at an attractive value.”

Adjusted EBITDA for the quarter came out to $1.66 million versus $1.2 million in the same quarter last year, “up 39%, despite pricing headwinds in our markets, particularly in Michigan,” the Strickler added. The gross margin was 63.4% in the quarter before fair value adjustments.

Grown Rogue held the crown for the top flower brand in Oregon for the sixth consecutive quarter, according to LeafLink’s MarketScape data. Over the year, total harvested wet weights for the state of Oregon fell 13% for indoor and 21% for outdoor, respectively. “In Oregon, we saw continued reduction in total supply as many cultivators exit or scale back their business, which should result in a pricing rebound in 2023,” Strickler said.

The company also closed on a $2 million convertible debenture financing arrangement over the period.

“It’s also great to see a shifting of investor sentiment towards strong operators and management teams reflected in our recently closed a $2 million convertible debt financing with Mindset Capital at very attractive terms to the company,” Strickler said. “We are planning to continue our disciplined approach to capital allocation as we look to accelerate expansion plans into new markets. I look forward to updating Grown Rogue shareholders on these efforts in the future.”

StaffJune 30, 2022


The Daily Hit is a recap of the top cannabis business stories for June 30, 2022.


Tyson 2.0 Raises $9M with Plans to Expand Celebrity Property

Cannabis advocate and former boxer  Mike Tyson’s cannabis brand Tyson 2.0 announced the close of its oversubscribed $9 Million Series A round led by JW Asset Management. Additional investors in the round include K2, Ambria Capital, Tress Capital, and Patrick Carroll. The company said that the new funds will be used to acquire more celebrity intellectual property, scale marketing efforts, accelerate distribution, and further invest in the development of Tyson 2.0’s house of brands strategy. Read more here.

Akerna Shares Plunge on New Offering

Despite being in financial trouble, cannabis tech firm Akerna Corp. (Nasdaq: KERN) announced the pricing of an underwritten public offering of 29,382,861 units with common stock warrants. The units are being sold at a public offering price of $0.23 per unit and the pre-funded units are being sold at a public offering price of $0.2299 per pre-funded unit. The news sent shares tumbling almost 50% in early trading to lately sell at 14 cents per share. The offering should bring in roughly $6.7 million. Read more here.

Grown Rogue Reports Rising Revenue as Prices Fall

Grown Rogue International Inc.  (CSE: GRIN) (OTC: GRUSF) reported its fiscal second-quarter 2022 results for the three months ending April 30, 2022. Grown Rogue reported revenue rose 72% to $4.7 million versus $1.37 million for the same time period last year. Sales also rose sequentially from the first quarter’s revenue of $3.73 million. Read more here.

Curaleaf Pushes Back on Tip Jar

Cannabis multi-state operator Curaleaf Holdings Inc.  (OTC: CURLF) is pushing back against an employee lawsuit that sued the company for the contents of a tip jar. Former employee Morgan Heller filed a complaint in March accusing the company of not giving the employees $126,000 that had been collected in tip jars. Heller says the managers took the money instead. Read more here.

Field Trip’s Clinics Cost More Than the Revenue They Bring In

Field Trip Health Ltd. (NASDAQ: FTRP) reported fiscal fourth-quarter and full-year 2022 results for the period ending March 31, 2022, and provided a business update today. All results are reported in Canadian dollars. For the quarter, Field Trip earned patient services revenues of $1,724,102 from its twelve clinics in operation, an increase of $1,197,667 or 228%, over the fourth quarter ended March 31, 2021. Read more here.

Psychedelic Microdosing is Trendy, but Studies are Lacking

Microdosing psychedelics is quickly becoming a trendy new mental and physical wellness event that athletes, celebrities, and everyday businesspeople are doing it as a daily ritual that is sometimes even encouraged by their bosses. In fact, the very term “microdosing” is working into common usage as just another way of saying you tried something, or attended some event, or ingested some substance — but just not a lot of it. Read more here.


Canopy Growth Corporation

Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) announced today that, further to its press release dated June 29, 2022, it has entered into an additional privately negotiated exchange agreement with a holder of the company’s outstanding 4.25% unsecured senior notes due 2023, to acquire approximately C$7.25 million (approximately USD$5.6 million) aggregate principal amount of the notes from the noteholders in exchange for common shares of the company and approximately C$140,000 (approximately USD$110,000) in cash for accrued and unpaid interest. Read more here.

MariMed, Inc.

MariMed, Inc. (OTCQX: MRMD), a multi-state cannabis operator, today announced that it has obtained a receipt for its final non-offering, long form prospectus dated June 29, 2022, from the Ontario Securities Commission. Concurrent with its prospectus filing, the Company also received conditional approval from the Canadian Securities Exchange to list the company’s common shares on the CSE under the symbol “MRMD”. Listing of the common shares is subject to the satisfaction of certain customary conditions, including the receipt by the CSE of all final documentation. Read more here.

Northern Lights Acquisition Corp., SHF Holding Co., LLC

Northern Lights Acquisition Corp. (Nasdaq: NLIT), a special purpose acquisition company, announced that it has amended that certain unit purchase agreement, dated February 11, 2022, by and among the company, 5AK, LLC, the company’s sponsor, SHF, LLC d/b/a Safe Harbor Financial, a Colorado limited liability company, SHF Holding Co., LLC, a Colorado limited liability company and the sole member of the target, and Partner Colorado Credit Union, a Colorado corporation and the sole member of the Seller, to extend the date by which the transactions contemplated thereby had to be consummated from June 30, 2022, until July 29, 2022, with the ability for the deadline to be extended through August 31, 2022. The extension of the outside date will provide the company with additional time to complete the business combination as it awaits regulatory approval. Read more here.

Ascend Wellness Holdings, Inc.

Ascend Wellness Holdings, Inc. (CSE: AAWH.U) (OTCQX: AAWH), a multi-state, vertically integrated cannabis operator, announced that it has closed on $28.5M of the remaining additional funding under the accordion feature of its existing term loan credit facility. As previously announced, the company drew initial funding of US$210M in August 2021 and subsequently closed on a US$36.5M expansion in May 2022. This additional raise brings the total raised under the senior credit facility to US$275M. Read more here.

Auxly Cannabis Group Inc.

Auxly Cannabis Group Inc. (TSX: XLY) (OTCQX: CBWTF) announced today the voting results from its annual general meeting of shareholders held on June 30, 2022. A total of 159,835,106 common shares of the company, representing 17.85% of the issued and outstanding common shares of the company, were voted in connection with the meeting by shareholders and proxy holders. All of the matters put forward before the company’s shareholders for consideration and approval, as set out in the company’s information circular dated May 20, 2022, were approved by the requisite majority of the votes cast at the meeting. Read more here.

Canntab Therapeutics Limited

Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) a developer in cannabinoid and terpene blends in hard pill form for therapeutic applications, provided a corporate update to its shareholders and stakeholders. Further to the announcement made by Canntab on April 14, 2022, with respect to our exploration of a variety of alternative business strategies including potential M&A opportunities, as well as identifying and negotiating partnerships to assist Canntab in expanding its product offerings in the United States and other international jurisdictions. Read more here.

Pervasip Corp. 

Pervasip Corp. (OTC: PVSP), a developer of companies and technologies in high value emerging markets, and Zen Asset Management, its wholly owned subsidiary today announced that its partnership with Full Spectrum Advisors is yielding results ahead of expectations. Following announcements made in March, introducing its partnership with Full Spectrum Advisors, Pervasip reports early results that are exceeding projected yield improvements with 25% increased harvest results in the cultivation centers growing Artizen flower. Read more here.

MediPharm Labs Corp.

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ), a pharmaceutical company specialized in precision-based cannabinoids, today announced the results of matters voted on at its annual meeting of holders of common shares held on Thursday, June 30, 2022. The voting results for each of the matters presented at the meeting are outlined below. Read more here.

Humble & Fume Inc.

Humble & Fume Inc. (CSE: HMBL) (OTCQX: HUMBF), a North American distributor for cannabis and cannabis accessories, announced the detailed voting results for the 2021 Annual General Meeting of Shareholders, held on June 29, 2022, which includes the election of Mark Hubler to the Board of Directors. Read more here.


StaffJune 30, 2022


Grown Rogue International Inc.  (CSE: GRIN) (OTC: GRUSF) reported its fiscal second-quarter 2022 results for the three months ending April 30, 2022. Grown Rogue reported revenue rose 72% to $4.7 million versus $1.37 million for the same time period last year. Sales also rose sequentially from the first quarter’s revenue of $3.73 million. 

The company delivered a net income of $144,734 versus last year’s net loss of $1.4 million. The company said this was the fourth consecutive quarter of positive net income and positive operating cash flow, before changes in working capital.

Grown Rogue had another very strong quarter, reporting positive operating cash flow, net income, and free cash flow,” said Obie Strickler, CEO of Grown Rogue. “In Q2, we estimate we had one of the lowest average indoor selling price of any public cannabis company at $872 per pound of whole flower ($1.92 per gram) while reporting 23% operating cash flow margins, before changes in working capital”, continued Mr. Strickler. “We continue to evaluate opportunities for new markets where we can bring our craft quality and efficiencies to provide better access for patients and consumers. Oregon had a particularly strong quarter with revenue up 70% quarter over quarter even while the overall market was down slightly. The company launched pre-rolls in Michigan during the quarter and we are excited about the initial receptivity in this category. I could not be more proud of our team as we were north of $1M in EBITDA for the third consecutive quarter and have established Grown Rogue as the consistent market leader in the Oregon flower market, one of the most competitive states in the US. We are laser-focused on continuing to become more efficient while staying on trend with leading genetics and quality.”

Revenue Breakdown

Breaking down the revenue results, Grown Rogue’s Oregon market delivered revenue of $2.36 million compared to $1.37 million in the second quarter of 2021, an increase of 72%. It also jumped from the first quarter’s revenue of $1.39 million.  The average selling price of indoor whole flower was $719 per pound. The price dropped from the first quarter price of $781 per pound. The monthly indoor production increased to approximately 800 pounds of whole flower in the second quarter, with expectations to be at or near 1,000 pounds per month in the third quarter.

The Michigan market reported revenue of $2.34 million compared to pro-forma revenue of $1.38 million in the second quarter of 2021, an increase of 70%, but flat from the first quarter’s sales. The average selling price of indoor whole flower was $1,182 per pound. The price also fell in Michigan from the first quarter’s $1,322 per pound. The monthly indoor production of whole flower increased to approximately 550 pounds in the second quarter of 2022, with expectations to be at or near 750 pounds per month in the third quarter.



StaffApril 4, 2022


Grown Rogue International Inc.  (CSE: GRIN) (OTC: GRUSF), a multi-state cannabis company with operations and assets in Oregon and Michigan, reports fiscal first-quarter 2022 results for the three months ending January 31, 2022. Grown Rogue reported first-quarter revenue of $3.73 million versus $1.05 million for the same time period in 2021, an increase of 255%. The net income for the quarter was $155,441.

The company said $1.3 million in sales came from Oregon while $2.3 million came from Michigan. Grown Rogue also said that it was the ninth consecutive quarter of positive EBITDA, including pro-forma results. The third consecutive quarter of positive operating cash flow, before changes in working capital, and the third consecutive quarter of the positive net income.

“Grown Rogue had a very strong quarter considering Q1 is typically the weakest quarter of our fiscal year”, said Obie Strickler, CEO of Grown Rogue. “Michigan was particularly strong with revenue up 10% quarter over quarter and Michigan state sales down 3% leading to large market share gains during the quarter. With our recent launch of pre-rolls in Michigan and continued build out of our 80,000 square foot facility, we expect further market share gains in 2022. I could not be more proud of our team as we were north of $1M in EBITDA for the second consecutive quarter and established Grown Rogue as the clear leader in the Oregon flower market, one of the most competitive states in the US. With our industry-leading efficiencies and rapidly expanding craft production, we are excited to kick off 2022, where we are focused on continuing to gain market share, by offering consistent quality and service and launching into additional product categories in our states. We expect additional economies of scale will lower our breakeven costs in 2022, even as our data suggests Grown Rogue has the lowest indoor production breakeven of any public company in the U.S.”

Grown Rogue closed a non-brokered private placement for gross proceeds of $1.30 million which included an investment from Bengal Capital, a venture capital firm with significant cannabis expertise, and the Company’s CEO

StaffMarch 1, 2022


Grown Rogue International Inc. (CSE: GRIN) (OTC: GRUSF) reported audited results for the fiscal year ended October 31, 2021. Total revenue for Grown Rogue in 2021 grew to $9.3 million versus $4.2 million for 2020. The company had a net loss of $1 million, which dropped from the previous year’s net loss of $2.3 million.

“Grown Rogue grew substantially in 2021 driven by continued expansion in Michigan and Oregon. We started 2021 producing approximately 200 pounds of indoor whole flower/month and ended the year producing more than 1250 pounds/month. Our focus on building the premier craft flower company at scale is being realized in all aspects of our business particularly quality, yield, and costs per pound.” said Obie Strickler, CEO of Grown Rogue. “Despite 2021 being a difficult year for our peers, we grew EBITDA ~800% year over year and achieved some of the highest margins in the industry, as a wholesaler in two very competitive markets. The company continues to gain market share in both Oregon and Michigan as our customers and retail partners value our quality, consistency, and service. Our recent soft launch of nitrogen sealed pre-rolls in Michigan has been well received and we are excited to push into additional product categories in 2022.”

Oregon’s sales were $5.1 million, while Michigan delivered revenue of $3.8 million. The company said that it was the fastest-growing brand in Oregon in September and October, according to LeafLink. It ended 2021 as a top 10 flower wholesaler in Michigan, according to LeafLink’s MarketScape.

The company said it had raised gross proceeds of $6.6 million in fiscal 2021 to fund expansion. It had total assets of $14.2M at year-end 2021 compared to $3.8M at year-end 2020, an increase of 277%. It retired senior secured convertible debentures and subsequent to year-end, Grown Rogue raised $1.3M in a non-brokered private placement; including $1.0M from Bengal Capital, a venture capital firm with significant cannabis expertise, and $0.3M from the company CEO.

William SumnerApril 24, 2019


It’s time for your Daily Hit of cannabis financial news for April 24, 2019.

On The Site

Cresco Labs

Chicago-based Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) released its unaudited financial results for the fourth quarter and full year ending December 31, 2018. The fourth quarter revenue was $17.0 million, an increase of 411% over last year for the same time period and up 33% sequentially. The company trimmed its net losses to $2.6 million versus the net loss of $3.0 million for 2017 fourth quarter. The quarter’s pro forma revenue was $22.5 million.

Federal Legalization – Then What?

It is fascinating to step back and observe how the mindset of many in the cannabis industry seems to work. Let’s think through a couple of scenarios and have a peek at the landscape in a post-legalization world. Let’s begin with the following

After the Drama, Where Is Aphria Headed Now?

Even in a space with as much excitement as marijuana stocks, Aphria (NYSE:APHA) stood out for having as much drama as a cable TV show. After all the excitement, what’s next for APHA stock? And have the company’s recent moves made it investable again, or is Aphria only appropriate for the most steel-nerved traders?

In Other News

Grown Rogue

Grown Rogue International Inc. (CSE:GRIN) (OTC: NVSIF), a vertically integrated multi-state cannabis operator, announced that it has entered into a binding letter of agreement to acquire Decibel Farms, Inc., an organic cannabis producer and processor. Under the terms of the transaction, the acquisition will be structured as a tax-free merger and shareholders of Decibel will receive $2 million. Decibel owners Shawn Bishop and Buddy Wilson will join Grown Rouge as Vice President of Manufacturing and President of Sales, respectively.


Aphria Inc. (TSX:APHA)(NYSE:APHA) announced that it has closed a $300 million private placement offering to institutional investors. The initial investors exercised their option to purchase an additional $50 million in notes, making the deal worth $350 million. The notes are senior unsecured obligations of Aphria with an interest rate 5.25% per year, payable semiannually on June 1 and December 1 of each year, beginning on December 1, 2019. The notes will mature on June 1, 2024.


TerrAscend Corp. (CSE:TER)(OTCQX: TRSSF) today released its financial results for the fourth quarter ending on December 31, 2019. Revenue for the quarter was $5 million, up from $1.8 million in the previous quarter. Net loss was $11.7 million or $0.13 per share. The company has $21.7 million in cash and cash equivalents. “We are pleased with our performance in the fourth quarter and have laid the groundwork for success in 2019,” said Michael Nashat, CEO of TerrAscend, in a statement. “We are experiencing strong sales momentum in Canada and are making substantial progress towards becoming a leading US multi-state operator.”

StaffJanuary 15, 2019


It’s time for your Daily Hit of cannabis financial news on January 15, 2019.

On The Site

Tilray. Inc. (NASDAQ: TLRY) has signed a long-term revenue-sharing agreement to market and distribute cannabis products with  Authentic Brands Group (ABG).

ABG houses more than 50 brands including well-known names like Airwalk and Frye shoes, Juicy Couture, Nautica, Nine West, Vince Camuto, and Spyder sportswear. It has a global retail footprint of over 100,000 points of sale and more than 4,500 branded freestanding stores and shop-in-shops. The company noted that ABG generates approximately $9 billion in retail sales annually.

In Other News

CANNAMERICA BRANDS CORP. (CSE: CANA) (OTCQB: CNNXF) has granted an aggregate of 2,450,000 incentive stock options to purchase common shares to certain officers, directors, and other eligible persons of the Company.  The options are exercisable, subject to vesting provisions, over a period of five years at a price of $0.60 per share, the closing price of the Company’s first tranche of its brokered private placement announced on January 10, 2019.

WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) and BLOCKSTRAIN TECHNOLOGY CORP.  (TSXV: DNAX.V) (OTC: DNAXF) has completed the ‘first-of-its-kind’ cannabis strain validation registration program – a testing and verification process that will confirm cannabis strains as purchased. BLOCKStrain, which developed a Master Genome Strain Registration and Clone Strain Registration program is focused on providing transparency and actionable quality assurance to cannabis consumers. Licensed producers completing the registration can in turn provide assurance to their own customers that the cannabis strains they purchase are the ones they receive.

Charlotte’s Web Holdings, Inc. (CSE: CWEB; OTCQX: CWBHF)  reported its 2018 harvested hemp results. The company reported more than a 10 times growth in harvested hemp compared to its 2017 grow season. The high-quality 100% U.S.-grown hemp will be processed through proprietary extraction methods to create whole plant hemp extract that will be used in Charlotte’s Web products for sale in 2019 and 2020.

Grown Rogue International Inc. (CSE: GRIN | OTC: NVSIF) announced the signing of a Memorandum of Understanding to expand its brand and products into Michigan through a strategic partnership with established local cannabis operators and investors. The expansion is anticipated to initially include two retail dispensaries, referred to as provisional centers in Michigan, a 19,000 sq ft indoor cultivation and processing center in Detroit, and an interest in a 28 acre parcel located in the northern portion of the lower peninsula which can be used for cultivation. Grown Rogue will make a further announcement relating to the definitive terms of the partnership which are currently being negotiated between the parties.

Flower One Holdings Inc. (CSE: FONE) (OTCQB: FLOOF) announced its first brand partnership for cannabis product fulfillment in Nevada. Flower One and Rapid Dose Therapeutics Inc. (CSE: DOSE) entered into a definitive agreement on January 10, 2019, pursuant to which Flower One has been granted a license to manufacture, distribute and sell RDT’s QuickStrip™, an innovative, proprietary delivery technology for the cannabis market in Nevada.

Medicine Man Technologies (MDCL), a leading consulting, IP licensing and products company in the cannabis industry, has signed binding term sheets and conditions for acquisition of MedPharm Holdings, LLC, intellectual property development and holding company focused on cannabis research and product/brand development.

Nouveau Life Pharmaceuticals, Inc. (USOTC: NOUV) (“NOUV”) and Puration, Inc. (USOTC: PURA) announced that Brian Shibley, the current CEO PURA has been appointed as the interim CEO of NOUV.  On October 4, 2018, PURA sold its cannabis cultivation business to NOUV in exchange for a $1.2 million convertible note with a commitment that the note would promptly be converted into shares of NOUV and that those converted shares would be distributed in a stock dividend to the shareholders of PURA.  The process of updating NOUV’s public filings in order to proceed with the dividend has taken longer than originally anticipated.  Brian Shibley’s appointment as CEO is anticipated to reaccelerate the update of NOUV public filings and in so doing, speed up the anticipated dividend of NOUV shares to PURA shareholders.

Leafly, the world’s leading cannabis information resource, and Flowhub, the award-winning cannabis compliance and point of sale provider, are today announcing their new, real-time integration to help cannabis dispensaries drive visibility and automate online menus. With the new Leafly and Flowhub integration, dispensaries can now automatically update their online menus on Leafly to match their live inventory in Flowhub’s industry-leading POS system. The Flowhub solution allows retailers and managers to save time on manual data entry, while providing accurate information and a seamless shopping experience for their potential customers on Leafly.

Debra BorchardtNovember 26, 2018


Grown Rogue International Inc. began trading today on the Canadian Securities
Exchange (CSE) under the ticker symbol “GRIN”. The listing follows the company’s previously announced reverse takeover (RTO) of a Canadian public company Novicius Corp.

The company raised approximately CAD $6.5 million through brokered and non-brokered private placements. Grown Rogue is only located in Oregon at this time. The company says it expects to enter the California market by the end of the year, but that doesn’t include cultivation or production of any sort.

Grown Rogue has signed an LOI  for a joint venture in northern California.  The company said its focus in California is to start with distribution, move into extraction (manufacturing), and ultimately retail. In fact, the filing states, “Grown Rogue believes California will ultimately see similar price compression as other recreational states and therefore does not anticipate constructing or operating cultivation facilities in California for several years. Grown Rogue does not currently hold any licenses to operate its business in California, and intends to obtain such required licenses prior to entering the California market.”

“Grown Rogue is a trusted brand with a proven track record for delivering reliable and consistent experiences for cannabis consumers,” said Obie Strickler, CEO and co-founder of Grown Rogue.  “With average consecutive monthly revenue growth of 28% for 2018, we have begun the process to expand operations and jurisdictions to meet increased demand. The public listing of the Company’s common shares on the CSE is an important milestone in the development of the Company, as we continue to accelerate our expansion as a national cannabis brand.”

So far this year in three quarters for fiscal year 2018, Grown Rogue has reported $1.1 million in revenues and $4.9 million in net losses.  As of July 31, 2018, Grown Rogue had cash of $100,685 and a working capital deficit of $876,637.

Strickler owns 39% of the company and while he has lent the company thousands of dollars numerous fees have been paid to individuals and companies related to Strickler. Grown Rogue pays Strickler $5,000 per month in rent for the Trails End Property and 2.5% of gross sales achieved at the property, all payable in cash. The rent owed by GRU Properties to Mr. Strickler is paid in cash at comparable market rates.

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.


By continuing I agree to your Privacy Policy and consent to receive relevant newsletters and other email communications on events, editorial features, and special partner offers from Green Market Report. I can unsubscribe or change my email preferences at any time.

About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


Recent Tweets

@GreenMarketRpt – 34 mins

Florida Medical Cannabis to Launch New Licensing Round, First Expansion Since 2017

@GreenMarketRpt – 42 mins

High Times Could End up With Chicago Lawyer Stephen Kunkle

Back to Top

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.


By continuing I agree to your Privacy Policy and consent to receive relevant newsletters and other email communications on events, editorial features, and special partner offers from Green Market Report. I can unsubscribe or change my email preferences at any time.